%20Bispecific?unique=e9932f1)
Gentaur Epcoritamab – Anti-CD3E / CD20 (MS4A1) Bispecific
Bridges T-cells to B-cells by binding CD3E and CD20, driving targeted B-cell depletion. Ideal for lymphoma and immunotherapy models.
Garantie satisfait ou remboursé de 30 jours
Livraison : 2-3 jours ouvrables